Watch for Ensifentrine (Ohtuvayre) for COPD
September 2024
Rx ensifentrine (Ohtuvayre) will be a new nebulized med for COPD.
It opens the airways and reduces inflammation in the lungs...to prevent flare-ups or worsening of COPD symptoms (coughing, wheezing, etc).
It’s used twice daily as a maintenance med...not prn like albuterol or ipratropium nebs.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote